Naoero vs Tonga: New cases tested for RR-/MDR-TB

Naoero
100.0%
in 2023
Tonga
100.0%
in 2023
Naoero rank
1st
Tonga rank
1st

New cases tested for RR-/MDR-TB over time

  • Naoero
  • Tonga
020406080100200920162023

How they compare

Naoero currently reports 100.0% against 100.0% in Tonga, a difference of 0.0%.

Across all 11 years both countries report, Tonga has been ahead every year.

Naoero ranks 1st and Tonga ranks 1st of 192 countries.

Tonga has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Naoero Tonga Difference Ahead
2010s 0.0% 42.9% 42.9% Tonga
2020s 75.0% 100.0% 25.0% Tonga

Averages of every year both report within each decade.

Frequently asked questions

Which has higher new cases tested for rr-/mdr-tb, Naoero or Tonga?
Naoero, at 100.0% against 100.0% in Tonga as of 2023.
What is the difference in new cases tested for rr-/mdr-tb between Naoero and Tonga?
0.0%, with Naoero ahead.
How many years of comparable data are there for Naoero and Tonga?
11 years are reported by both, from 2011 to 2023.
How do Naoero and Tonga rank globally for new cases tested for rr-/mdr-tb?
Naoero ranks 1st and Tonga ranks 1st of 192 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Naoero vs Tonga: New cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 02 September 2026, from https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/naoero/tonga/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/naoero/tonga/">Naoero vs Tonga: New cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
205 places, 3,388 data points, 2005–2024
Last refreshed